PHARMACOGENETICS OF METHYLPHENIDATE RESPONSE AND TOLERABILITY IN PEDIATRIC PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: CONTRIBUTION OF DOPAMINE GENES AND PRENATAL EXPOSURE TO NICOTINE

被引：0
|
作者：
Ribases, Marta [1 ]
Pagerols, Mireia [2 ]
Richarte, Vanessa [3 ]
Sanchez-Mora, Cristina [4 ]
Garcia-Martinez, Iris [5 ]
Corrales, Montse [3 ]
Corominas, Margarita [3 ]
Cormand, Bru [6 ]
Casas, Miguel [3 ]
Antoni Ramos-Quiroga, Josep [3 ]
机构：
[1] Mental Hlth & Addict Vall dHebron Res Inst VHIR, Grp Psychiat, Psychiat Genet Unit, Barcelona, Spain
[2] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Psychiat Genet Unit, Barcelona, Spain
[3] Hosp Univ Vall dHebron, Dept Psychiat, Barcelona, Spain
[4] Inst Recerca Hosp Unv Vall Hebr, Pschiat Genet, Barcelona, Spain
[5] Vall dHebron Res Inst, Psychiat Genet Unit, Barcelona, Spain
[6] Univ Barcelona, Dept Genet, Fac Biol, Barcelona, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Sa4
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [1] Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder
    Pagerols, M.
    Richarte, V.
    Sanchez-Mora, C.
    Garcia-Martinez, I.
    Corrales, M.
    Corominas, M.
    Cormand, B.
    Casas, M.
    Ribases, M.
    Ramos-Quiroga, J. A.
    [J]. PHARMACOGENOMICS JOURNAL, 2017, 17 (01): : 98 - 104
  • [2] Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder
    M Pagerols
    V Richarte
    C Sánchez-Mora
    I Garcia-Martínez
    M Corrales
    M Corominas
    B Cormand
    M Casas
    M Ribasés
    J A Ramos-Quiroga
    [J]. The Pharmacogenomics Journal, 2017, 17 : 98 - 104
  • [3] Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder
    Roman, T
    Szobot, C
    Martins, D
    Biederman, J
    Rohde, LA
    Hutz, MH
    [J]. PHARMACOGENETICS, 2002, 12 (06): : 497 - 499
  • [4] Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): A systematic review
    Contini, Veronica
    Rovaris, Diego L.
    Victor, Marcelo M.
    Grevet, Eugenio H.
    Rohde, Luis A.
    Bau, Claiton H. D.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (06) : 555 - 560
  • [5] Response to methylphenidate in boys with attention-deficit hyperactivity disorder
    Zeiner, P
    Bryhn, G
    Bjercke, C
    Truyen, K
    Strand, G
    [J]. ACTA PAEDIATRICA, 1999, 88 (03) : 298 - 303
  • [6] Methylphenidate for Attention-Deficit/Hyperactivity Disorder
    Romanos, Marcel
    Reif, Andreas
    Banaschewski, Tobias
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (09): : 994 - 995
  • [7] Methylphenidate and attention-deficit hyperactivity disorder
    Mellis, Craig
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2016, 52 (03) : 354 - 355
  • [8] Dopamine genes and attention-deficit hyperactivity disorder: a review
    DiMaio, S
    Grizenko, N
    Joober, R
    [J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2003, 28 (01): : 27 - 38
  • [9] Dopamine receptor gene influences response to methylphenidate therapy in attention-deficit/hyperactivity disorder
    不详
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (06) : 849 - 849
  • [10] Use of methylphenidate in attention-deficit hyperactivity disorder
    Jean-Tron, Maria G.
    Marquez-Gonzalez, Horacio
    Barragan-Perez, Eduardo
    Barajas-Nava, Leticia A.
    [J]. BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2020, 77 (01): : 42 - 45
12345